These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21489803)

  • 1. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
    Albohy A; Mohan S; Zheng RB; Pinto BM; Cairo CW
    Bioorg Med Chem; 2011 May; 19(9):2817-22. PubMed ID: 21489803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
    Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
    Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
    Mohan S; McAtamney S; Haselhorst T; von Itzstein M; Pinto BM
    J Med Chem; 2010 Oct; 53(20):7377-91. PubMed ID: 20873795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.
    Kongkamnerd J; Cappelletti L; Prandi A; Seneci P; Rungrotmongkol T; Jongaroonngamsang N; Rojsitthisak P; Frecer V; Milani A; Cattoli G; Terregino C; Capua I; Beneduce L; Gallotta A; Pengo P; Fassina G; Miertus S; De-Eknamkul W
    Bioorg Med Chem; 2012 Mar; 20(6):2152-7. PubMed ID: 22342267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
    Zhang H; Wang K; Zhu H; Zhao X; Zhao H; Lei Z; Chen B; Yang F; Liu K; Zhang K; Wang J; Tian Y
    Eur J Med Chem; 2020 Aug; 200():112423. PubMed ID: 32512482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploitation of the catalytic site and 150 cavity for design of influenza A neuraminidase inhibitors.
    Adabala PJ; LeGresley EB; Bance N; Niikura M; Pinto BM
    J Org Chem; 2013 Nov; 78(21):10867-77. PubMed ID: 24090215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
    Stanley M; Martin SR; Birge M; Carbain B; Streicher H
    Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro.
    Niikura M; Bance N; Mohan S; Mario Pinto B
    Antiviral Res; 2011 Jun; 90(3):160-3. PubMed ID: 21443905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase.
    Zhao H; Jiang S; Ye Z; Zhu H; Hu B; Meng P; Hu Y; Zhang H; Wang K; Wang J; Tian Y
    Eur J Med Chem; 2021 Oct; 221():113567. PubMed ID: 34082224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitors.
    Jia R; Zhang J; Ai W; Ding X; Desta S; Sun L; Sun Z; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2019 Sep; 178():64-80. PubMed ID: 31176096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of NH
    Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
    Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
    Ai W; Zhang J; Zalloum WA; Jia R; Cherukupalli S; Ding X; Sun Z; Sun L; Jiang X; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2020 Apr; 191():112147. PubMed ID: 32092589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
    Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
    J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of viral group-1 and group-2 neuraminidases by oseltamivir: A comparative structural analysis by the ScrewFit algorithm.
    Calligari PA; Kneller GR; Giansanti A; Ascenzi P; Porrello A; Bocedi A
    Biophys Chem; 2009 Apr; 141(1):117-23. PubMed ID: 19195766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity.
    Richards MR; Guo T; Hunter CD; Cairo CW
    Bioorg Med Chem; 2018 Oct; 26(19):5349-5358. PubMed ID: 29903413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 19. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS; Wang SQ; Chou KC
    Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
    Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S
    Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.